Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05565781

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05565781
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05565781. Randomized; no masking; primary purpose screening. Start 2022-03-28 (actual); primary completion 2025-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke
Acronym
SMARTTHUNDER
Condition
Paroxysmal Atrial Fibrillation
Condition
Cryptogenic Stroke
Intervention (Device)
ECG (electrocardiogram) smartwatch
Intervention (Device)
Insertable Cardiac Monitor (ICM)
Intervention (Device)
External ECG Monitoring
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute (class: other)

Record details

Record id
cardio:ct-nct05565781
Content hash
3754d64616805400a6709001d2ea9db049597963c3949f3f2b2ef950d9a2a009